We found 5 drugmaker programs for Hereditary Angioedema medicines and 3 charity funds (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Hereditary Angioedema depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Travel to care for HAE-related reasons (e.g. seeing a specialist).
Covers: Copays for FDA-approved medications (plus travel for some funds).
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
CSL Behring copay program may cover eligible out-of-pocket costs for commercially insured patients; subject to terms and conditions.
QuickStart Program ships a 1-month supply at no cost; eligible patients may get up to 2 months free during insurance approval.
Dedicated case manager helps with insurance navigation; nursing team offers injection training and product support.
The Andembry page also mentions help getting therapy at little to no cost and resources for government-insured patients, but does not give eligibility details. CSL Behring lists Andembry as part of its copay program.
A dedicated Patient Education Manager plus help navigating insurance coverage and getting DAWNZERA delivered by the program's specialty pharmacy.
Commercially insured patients may pay as little as $0 per prescription. Not available to anyone using Medicare, Medicaid, TRICARE, VA or other government programs.
Quick-start shipment if coverage is delayed, and a short-term free supply during a temporary gap in commercial insurance, for eligible patients.
Patients without affordable insurance may get DAWNZERA at no cost through the Ionis Every Step Patient Assistance Program; financial application and yearly reapplication required.
Brochure also mentions a one-time, one-dose free trial for new patients (terms at DAWNZERA.com/FreeTrialProgram). Phone line Mon-Fri 8 AM-8 PM ET.
A dedicated Care Manager helps with insurance coverage, checks eligibility for financial support, and works with your specialty pharmacy.
Eligible commercially insured patients may pay as little as $0; program maximum applies. Medicare, Medicaid, TRICARE, VA and other government plans are not eligible.
QuickStart Program: temporary treatment options for new patients while waiting for a coverage decision.
Official pages do not describe a free-drug program for uninsured patients; ask KalVista Cares. Mon-Fri 8:30 AM-8 PM ET.
Eligible patients may pay as little as $0 for treatment. Not valid for prescriptions paid in whole or part by federal or state programs.
Dedicated patient support manager helps manage insurance, coordinates refills and shipments; clinical team including pharmacists and a nurse available 24/7.
Empower Patient Services is both the specialty pharmacy and the support program for Orladeyo. Copay terms are available from the Empower team. The page says patients can start regardless of insurance type but does not describe a free-drug program.
Co-pays may be covered at 100% up to the program maximum for patients enrolled in Takeda Patient Support with commercial insurance.
Insurance navigation, coordination of first shipment, and community resources.
No free-drug program described.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 5 drugmaker programs for Hereditary Angioedema medicines and 3 charity funds, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Hereditary Angioedema, 0 charity funds on this page accept Medicare, and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, The Assistance Fund's Hereditary Angioedema (HAE) fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Hereditary Angioedema medicines, 1 offers free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (The Assistance Fund, US Hereditary Angioedema Association, Good Days) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
